-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Isatuximab in Natural Killer Cell Lymphomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Isatuximab in Natural Killer Cell Lymphomas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Isatuximab in Natural Killer Cell Lymphomas Drug Details: Isatuximab...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SW-1115C3 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SW-1115C3 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SW-1115C3 in Non-Small Cell Lung Cancer Drug Details: SW-1115C3 is...
-
Product Insights
NewMonkeypox – Drugs In Development, 2024
Empower your strategies with our Monkeypox – Drugs In Development, 2024 report and make more profitable business decisions. Mpox, caused by the monkeypox virus, is an infectious disease presenting with a painful rash, fever, and enlarged lymph nodes. While most individuals fully recover, some may experience severe illness. Person-to-person transmission occurs through direct contact with infectious skin or lesions, including those in the mouth or genitals. Symptoms manifest from 1-21 days after exposure, lasting 2-4 weeks or longer in individuals with...
-
Product Insights
NewHerpes Zoster (Shingles) – Drugs In Development, 2024
Empower your strategies with our Herpes Zoster (Shingles) – Drugs In Development, 2024 report and make more profitable business decisions. Shingles (herpes zoster) is a painful, blistering skin rash. It is caused by the varicella-zoster virus. Symptoms may include fever and chills, headache, joint pain, and swollen glands. The predisposing factors include age and weakened immune system. Treatment includes antihistamines and pain relievers. The Herpes Zoster (Shingles) drugs in development market research report provide comprehensive information on the therapeutics under development...
-
Product Insights
NewVaricella Zoster (HHV-3) Infections – Drugs In Development, 2024
Empower your strategies with our Varicella Zoster (HHV-3) Infections – Drugs In Development, 2024 report and make more profitable business decisions. Varicella-zoster virus (VZV), also known as human herpesvirus 3 (HHV-3), causes two distinct infections: chickenpox (varicella) and shingles (herpes zoster). Varicella is a highly contagious viral infection characterized by an itchy rash with red spots and fluid-filled blisters that break open and form scabs. It spreads through respiratory droplets and direct contact with the rash. Varicella commonly affects children, and...
-
Product Insights
NewRabies – Drugs In Development, 2024
Empower your strategies with our Rabies – Drugs In Development, 2024 report and make more profitable business decisions. Rabies is a deadly virus spread to people from the saliva of infected animals. The rabies virus is usually transmitted through a bite. Symptoms include loss of feeling in an area of the body, loss of muscle function, difficulty swallowing, excitability, fever, and convulsions. The predisposing factors include exposure to wildlife and exposure to pets that are not vaccinated. The Rabies drugs in...
-
Product Insights
NewLymphocryptovirus Infections – Drugs In Development, 2024
Empower your strategies with our Lymphocryptovirus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Lymphocryptovirus infections are caused by a genus of herpesviruses that infect humans and other primates. The most well-known lymphocryptovirus is the Epstein-Barr virus (EBV), which can cause mononucleosis, lymphoma, and nasopharyngeal carcinoma in humans. Lymphocryptovirus infections are usually latent, meaning that the virus remains dormant in the host cells until it is reactivated by stress or immune suppression. Lymphocryptovirus infections can be...